Page last updated: 2024-08-24

hrp 112 and Experimental Mammary Neoplasms

hrp 112 has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cookson, KM	1

Other Studies

1 other study(ies) available for hrp 112 and Experimental Mammary Neoplasms

Article	Year
The parenteral toxicity of Cyclofem. Contraception, 1994, Volume: 49, Issue:4 Topics: Adenocarcinoma; Animals; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred ICR; Pituitary Neoplasms; Rabbits; Rats	1994

Article

Year

The parenteral toxicity of Cyclofem.

Contraception, 1994, Volume: 49, Issue:4

Topics: Adenocarcinoma; Animals; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred ICR; Pituitary Neoplasms; Rabbits; Rats

1994